Ayhan, M. Et Al. 2021. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?. Current problems in cancer , vol.45 .

Ayhan, M., Turan, N., Köstek, O., Tufan, G., Tataroğlu, Ö., Odabas, H., ... Sakin, A.(2021). Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?. Current problems in cancer , vol.45.

Ayhan, M Et Al. "Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?," Current problems in cancer , vol.45, 2021

Ayhan, M Et Al. "Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?." Current problems in cancer , vol.45, 2021

Ayhan, M. Et Al. (2021) . "Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?." Current problems in cancer , vol.45.

@article{article, author={M Ayhan Et Al. }, title={Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?}, journal={Current problems in cancer}, year=2021}